Hepatitis A Global Clinical Trials Review, H1, 2012


#120714

71pages

GlobalData

$ 2500

In Stock


GlobalData's clinical trial report, Hepatitis A Global Clinical Trials Review, H1, 2012" provides data on the Hepatitis A clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis A. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis A. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords

Hepatitis A Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Hepatitis A , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents

Table of Contents 2

List of Tables 4
List of Figures 5
Introduction 6
Hepatitis A 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Hepatitis A 23
Subjects Recruited Over a Period of Time 24
Prominent Sponsors 25
Top Companies Participating in Hepatitis A Therapeutics Clinical Trials 27
Prominent Drug Comparison 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
GlaxoSmithKline plc 30
Clinical Trial Overview of GlaxoSmithKline plc 30
Merck & Co., Inc. 32
Clinical Trial Overview of Merck & Co., Inc. 32
Sanofi 33
Clinical Trial Overview of Sanofi 33
Crucell Holland B.V 34
Clinical Trial Overview of Crucell Holland B.V 34
Crucell Switzerland AG 35
Clinical Trial Overview of Crucell Switzerland AG 35
Sinovac Biotech Co., Ltd. 36
Clinical Trial Overview of Sinovac Biotech Co., Ltd. 36
IDEWE Leuven 37
Clinical Trial Overview of IDEWE Leuven 37
Berna Products Corp. 38
Clinical Trial Overview of Berna Products Corp. 38
Wockhardt Limited 39
Clinical Trial Overview of Wockhardt Limited 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Clinical Trial Overview of Top Universities / Institutes / Hospitals 41
Centers for Disease Control and Prevention 41
Clinical Trial Overview of Centers for Disease Control and Prevention 41
University of Maryland School of Medicine 42
Clinical Trial Overview of University of Maryland School of Medicine 42
University of Sao Paulo General Hospital 43
Clinical Trial Overview of University of Sao Paulo General Hospital 43
Ewha Womans University 44
Clinical Trial Overview of Ewha Womans University 44
Academic Hospital Maastricht 45
Clinical Trial Overview of Academic Hospital Maastricht 45
Asan Medical Center 46
Clinical Trial Overview of Asan Medical Center 46
University of Geneva 47
Clinical Trial Overview of University of Geneva 47
Rijnstate Hospital 48
Clinical Trial Overview of Rijnstate Hospital 48
Aalborg Hospital 49
Clinical Trial Overview of Aalborg Hospital 49
National Taiwan University Hospital 50
Clinical Trial Overview of National Taiwan University Hospital 50
Federal University of Sao Paulo 51
Clinical Trial Overview of Federal University of Sao Paulo 51
Five Key Clinical Profiles 52

Appendix 68
Abbreviations 68
Definitions 68
Research Methodology 69
Secondary Research 69
About GlobalData 70
Contact Us 70
Disclaimer 70
Source 71

Hepatitis A Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7
Hepatitis A Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Hepatitis A Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Hepatitis A Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 10
Hepatitis A Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11
Hepatitis A Therapeutics Clinical Trials, North America, Top Countries, 2012* 12
Hepatitis A Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13
Hepatitis A Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 14
Hepatitis A Therapeutics Clinical Trials, BRIC Countries, 2012* 15
Hepatitis A Therapeutics Clinical Trials, G7 Countries, 2012* 16
Hepatitis A Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17
Hepatitis A Therapeutics Clinical Trials, E7 Countries, 2012* 18
Hepatitis A Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19
Hepatitis A Therapeutics Market, Global, Clinical Trials by Phase, 2012* 20
Hepatitis A Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 21
Hepatitis A Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22
Hepatitis A Therapeutics Market, Global, Terminated Clinical Trials, 2012* 23
Hepatitis A Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 24
Hepatitis A Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 26
Hepatitis A Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 28
Hepatitis A Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 29
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 30
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 32
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 33
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by Crucell Holland B.V, 2012* 34
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by Crucell Switzerland AG, 2012* 35
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by Sinovac Biotech Co., Ltd., 2012* 36
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by IDEWE Leuven, 2012* 37
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by Berna Products Corp., 2012* 38
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by Wockhardt Limited, 2012* 39
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 40
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2012* 41
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland School of Medicine, 2012* 42
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo General Hospital, 2012* 43
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by Ewha Womans University, 2012* 44
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Hospital Maastricht, 2012* 45
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2012* 46
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Geneva, 2012* 47
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by Rijnstate Hospital, 2012* 48
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by Aalborg Hospital, 2012* 49
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 50
Hepatitis A Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2012* 51
Hepatitis A Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
Hepatitis A Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Hepatitis A Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Hepatitis A Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 10
Hepatitis A Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11
Hepatitis A Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12
Hepatitis A Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 13
Hepatitis A Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 14
Hepatitis A Therapeutics Clinical Trials, BRIC Countries (%), 2012* 15
Hepatitis A Therapeutics Clinical Trials, G7 Countries (%), 2012* 16
Hepatitis A Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17
Hepatitis A Therapeutics Clinical Trials, E7 Countries (%), 2012* 18
Hepatitis A Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19
Hepatitis A Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 20
Hepatitis A Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 21
Hepatitis A Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22
Hepatitis A Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 24
Hepatitis A Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25
Hepatitis A Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 27
Hepatitis A Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 29
GlobalData Methodology 69